Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neslihan Meric

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 20, 2022
Patients experienced serious adverse reactions within one hour of hematopoietic stem-cell infusionNeslihan Meric, Ayhan Parmaksız, Zafer Gulbas
Advances in Experimental Medicine and Biology|December 6, 2019
Developments in Artificial Platelet and Erythroid Transfusion ProductsNeslihan Meric, Gulen Guney Esken, Merve Uslu, et al.
Genetic Testing and Molecular Biomarkers|December 17, 2010
Investigation of association between Angiotensin-converting enzyme gene insertion/deletion polymorphism frequency in Turkish patients with schizophreniaNeslihan Meric Baskan, Ayse Basaran, Cinar Yenilmez, et al.
Current Cancer Drug Targets|September 6, 2018
c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 ExpressionMerve Aksoz, Esra Albayrak, Galip Servet Aslan, et al.
Scientific Reports|May 16, 2020
Development of Small Molecule MEIS Inhibitors that modulate HSC activityRaife Dilek Turan, Esra Albayrak, Merve Uslu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 20, 2022
Patients experienced serious adverse reactions within one hour of hematopoietic stem-cell infusionNeslihan Meric, Ayhan Parmaksız, Zafer Gulbas
Advances in Experimental Medicine and Biology|December 6, 2019
Developments in Artificial Platelet and Erythroid Transfusion ProductsNeslihan Meric, Gulen Guney Esken, Merve Uslu, et al.
Genetic Testing and Molecular Biomarkers|December 17, 2010
Investigation of association between Angiotensin-converting enzyme gene insertion/deletion polymorphism frequency in Turkish patients with schizophreniaNeslihan Meric Baskan, Ayse Basaran, Cinar Yenilmez, et al.
Current Cancer Drug Targets|September 6, 2018
c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 ExpressionMerve Aksoz, Esra Albayrak, Galip Servet Aslan, et al.
Scientific Reports|May 16, 2020
Development of Small Molecule MEIS Inhibitors that modulate HSC activityRaife Dilek Turan, Esra Albayrak, Merve Uslu, et al.
Pageof 1